All terms in DOID
| Label | Id | Description |
|---|---|---|
| achalasia microcephaly syndrome | DOID_0050796 | [A syndrome that is characterized by microcephaly, intellectual deficit and early onset symptoms of achalasia (abnormal enlargement of the esophagus, impaired peristalsis, cardiospasm, recurrent vomiting and respiratory infections).] |
| hemangioma of lung | DOID_490 | |
| obsolete mycosis fungoides involving intra-abdominal lymph nodes | DOID_9109 | |
| guanidinoacetate methyltransferase deficiency | DOID_0050799 | [A cerebral creatine deficiency syndrome that is characterized by severe intellectual disability, seizures, speech problems and involuntary movements, has_material_basis_in homozygous or compound heterozygous mutation in the GAMT gene on chromosome 19p13.] |
| cerebral creatine deficiency syndrome | DOID_0050798 | [An amino acid metabolic disorder that is characterized by mental retardation, severe speech delay, behavioral abnormalities and seizures, has_material_basis_in mutation in the creatine transporter gene on chromosome Xq28.] |
| sclerosing hemangioma | DOID_495 | |
| acquired hemangioma | DOID_492 | |
| Opitz-GBBB syndrome | DOID_0050780 | [A monogenic disease that is characterized by hypertelorism, hypospadias, and additional midline defects resulting from mutations to the MID1 gene in the X-linked form or from a deletion on chromosome 22q11.2 in the autosomal dominant form.] |
| Zollinger-Ellison syndrome | DOID_0050782 | [A syndrome that is characterized by the development of a one or more tumors (gastrinoma) in the pancreas, duodenum, or both that secrete excessive levels of gastrin, a hormone that stimulates production of acid by the stomach.] |
| Ogden syndrome | DOID_0050781 | [A syndrome characterized by postnatal growth failure, severely delayed psychomotor development, variable dysmorphic features, and hypotonia and has_material_basis_in X-linked recessive or X-linked dominant mutation in the NAA10 gene on chromosome Xq28.] |
| primary progressive multiple sclerosis | DOID_0050784 | [A multiple sclerosis that is characterized by steady worsening of neurologic functioning, without any distinct relapses or periods of remission. The rate of progression may vary over time, with occasional plateaus or temporary improvements, but the progression is continuous.] |
| neuroectodermal tumor | DOID_171 | |
| secondary progressive multiple sclerosis | DOID_0050783 | [A multiple sclerosis that is characterised by a worsening of disability, rather than by relapses followed by recovery, which progressively worsens until a steady progression of disability replaces the cycles of attacks.] |
| cartilage cancer | DOID_0060102 | [A connective tissue tumor that can be a benign chondroma or a maligannt chondrosarcoma.] |
| gene_silenced_by_DNA_methylation | SO_0000129 | [A gene that is silenced by DNA methylation.] |
| gene_silenced_by_DNA_modification | SO_0000128 | [A gene that is silenced by DNA modification.] |
| insulator_binding_site | SO_0001460 | [A binding site that, in an insulator region of a nucleotide molecule, interacts selectively and non-covalently with polypeptide residues.] |
| contig_collection | SO_0001462 | [A collection of contigs.] |
| transcriptionally_regulated | SO_0000123 | [An attribute describing a gene that is regulated at transcription.] |
| lincRNA | SO_0001463 | [Long, intervening non-coding RNA. A transcript that does not overlap within the start or end genomic coordinates of a coding gene or pseudogene on either strand.] |